These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11844642)

  • 1. Glutamine supplementation and GH/IGF-I treatment in critically ill patients: effects on glutamine metabolism and protein balance.
    Umpleby AM; Carroll PV; Russell-Jones DL; Treacher DF; Jackson NC
    Nutrition; 2002 Feb; 18(2):127-9. PubMed ID: 11844642
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of glutamine supplementation, GH, and IGF-I on glutamine metabolism in critically ill patients.
    Jackson NC; Carroll PV; Russell-Jones DL; Sönksen PH; Treacher DF; Umpleby AM
    Am J Physiol Endocrinol Metab; 2000 Feb; 278(2):E226-33. PubMed ID: 10662706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness.
    Carroll PV; Jackson NC; Russell-Jones DL; Treacher DF; Sönksen PH; Umpleby AM
    Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E151-7. PubMed ID: 12759221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic response of muscle to alanine, glutamine, and valine supplementation during severe illness.
    Gore DC; Wolfe RR
    JPEN J Parenter Enteral Nutr; 2003; 27(5):307-14. PubMed ID: 12971729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the glutamine story over?
    Smedberg M; Wernerman J
    Crit Care; 2016 Nov; 20(1):361. PubMed ID: 27829456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of parenteral glutamine supplementation on glucose homeostasis in critically ill polytrauma patients--A randomized-controlled clinical study.
    Grintescu IM; Luca Vasiliu I; Cucereanu Badica I; Mirea L; Pavelescu D; Balanescu A; Grintescu IC
    Clin Nutr; 2015 Jun; 34(3):377-82. PubMed ID: 24931756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamine in critically ill patients: trial-sequential analysis.
    Maratea D; Fadda V; Trippoli S; Messori A
    Clin Nutr; 2014 Aug; 33(4):735-6. PubMed ID: 24582923
    [No Abstract]   [Full Text] [Related]  

  • 8. Glutamine supplementation fails to affect muscle protein kinetics in critically ill patients.
    Gore DC; Wolfe RR
    JPEN J Parenter Enteral Nutr; 2002; 26(6):342-9; discussion 349-50. PubMed ID: 12405645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glutamine supplementation in critically ill patients.
    Wernerman J
    Curr Opin Anaesthesiol; 2008 Apr; 21(2):155-9. PubMed ID: 18443481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine: an obligatory parenteral nutrition substrate in critical care therapy.
    Stehle P; Kuhn KS
    Biomed Res Int; 2015; 2015():545467. PubMed ID: 26495301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent intravenous pulses of growth hormone together with alanylglutamine supplementation in prolonged critical illness after multiple trauma: effects on glucose control, plasma IGF-I and glutamine.
    Duska F; Fric M; Pazout J; Waldauf P; Tůma P; Pachl J
    Growth Horm IGF Res; 2008 Feb; 18(1):82-7. PubMed ID: 17709266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamine supplementation in the critically ill: friend or foe?
    Oudemans-van Straaten HM; van Zanten AR
    Crit Care; 2014 May; 18(3):143. PubMed ID: 25032515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness.
    Mesotten D; Wouters PJ; Peeters RP; Hardman KV; Holly JM; Baxter RC; Van den Berghe G
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3105-13. PubMed ID: 15240578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutamine-enhanced nutrition in the critically ill patient.
    Andrews F; Griffiths R
    Hosp Med; 2002 Mar; 63(3):144-7. PubMed ID: 11933816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamine supplementation to critically ill patients?
    Wernerman J
    Crit Care; 2014 Mar; 18(2):214. PubMed ID: 25029635
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth hormone treatment prevents the decrease in insulin-like growth factor I gene expression in patients undergoing abdominal surgery.
    Bjarnason R; Wickelgren R; Hermansson M; Hammarqvist F; Carlsson B; Carlsson LM
    J Clin Endocrinol Metab; 1998 May; 83(5):1566-72. PubMed ID: 9589657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamine Supplementation for Critically Ill Adults: A summary of findings from the Cochrane Library with implications for critical care nursing.
    Sandoval CP
    Crit Care Nurse; 2015 Dec; 35(6):71-2. PubMed ID: 26628549
    [No Abstract]   [Full Text] [Related]  

  • 18. Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation.
    Mori M; Rooyackers O; Smedberg M; Tjäder I; Norberg A; Wernerman J
    Crit Care; 2014 Apr; 18(2):R72. PubMed ID: 24731231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects and therapeutic potential of glutamine in the critically ill surgical patient.
    Pastores SM; Kvetan V; Katz DP
    Nutrition; 1994; 10(5):385-91. PubMed ID: 7819649
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment with GH and IGF-1 in critical illness.
    Teng Chung T; Hinds CJ
    Crit Care Clin; 2006 Jan; 22(1):29-40, vi. PubMed ID: 16399018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.